CURRENT CONCEPTS IN RADIOTHERAPY FOR BENIGN DISORDERS

CurrentConceptsinRadiotherapyforBenignDisorders1-0-25kapak

Bursitis and Tendinitis

Berrin BENLİ YAVUZa , Duygu GEDİKb
aNecmettin Erbakan University Faculty of Medicine, Department of Radiation Oncology, Konya, Türkiye
bKartal Dr. Lutfi Kırdar City Hospital, Clinic of Radiation Oncology, İstanbul, Türkiye

Benli Yavuz B, Gedik D. Bursitis and tendinitis. In: Uysal B, Gamsız H, eds. Current Concepts in Radiotherapy for Benign Disorders. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.14-7.

ABSTRACT
Tendonitis and bursitis are inflammatory conditions that cause pain. Low-dose radiotherapy (LDRT) can be used as an alternative treatment in patients who do not improve with standard treatments such as analgesics, physical therapy, or steroid injections, who progress, and who cannot undergo surgery. LDRT may improve pain management by reducing inflammation. Radiotherapy (RT) should be given at a lower dose, in a smaller area, with shorter radiotherapy schemes. However, quality control and radiotherapy planning are the same as in malignant tumors. The recommended dose is 0.5-1 Gy per fraction, 3-6 Gy in total, and 2-3 fractions per week. It is an alternative treatment, especially in elderly patients with multiple morbidities.

Keywords: Radiotherapy; tendinopathy; bursitis

Referanslar

  1. Ott OJ, Niewald M, Weitmann HD, Jacob I, Adamietz IA, schaefer U, et al. German Cooperative Group on Radiotherapy for Benign Diseases (GCGBD). DEGRO guidelines for the radiotherapy of non-malignant disorders. part II: painful degenerative skeletal disorders. strahlenther Onkol. 2015;191(1):1-6. [Crossref]  [PubMed]
  2. Staruch M, Gomez S, Rogers S, Takacs I, Kern T, Adler S, et al. Low-dose radiotherapy for greater trochanteric pain syndrome-a single-centre analysis. Strahlenther Onkol. 2024;200(2):128-33. [Crossref]  [PubMed]  [PMC]
  3. Micke O, seegenschmiedt MH, Adamietz IA, Kundt G, Fakhrian K, Schaefer U, et al; German Cooperative Group on Radiotherapy for Nonmalignant Diseases (GCG-BD). Low-Dose Radiation Therapy for Benign painful skeletal Disorders: The Typical Treatment for the Elderly patient? Int J Radiat Oncol Biol Phys. 2017;98(4):958-63. [Crossref]  [PubMed]
  4. Yıldırım HC, Dinçbaş FÖ, Demircan V, Beyzadeoğlu M, Tekçe E, Yazıcı G, et al. Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish society for Radiation Oncology (TROD 05-002). strahlenther Onkol. 2024;200(2):143-50. [Crossref]  [PubMed]
  5. Pluta E, Ciepiela M, patla A, Mucha-Malecka A, Michta A, Wrobel-Radecka R, et al. Evaluating the Efficacy of Low Dose Radiotherapy in the Treatment of painful, Benign Musculoskeletal Conditions. Medical Rehabilitation. 2022; 26(4):4-10. [Crossref]
  6. Seegenschmiedt MH, Micke O, Muecke R; German Cooperative Group on Radiotherapy for Non-malignant Diseases (GCG-BD). Radiotherapy for nonmalignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol. 2015;88(1051):20150080. [Crossref]  [PubMed]  [PMC]
  7. Brown SA, Jaboin JJ, Eng TY, Bazan JG, Thomas CR. Nonmalignant disease. In: Halperin EC, Wazer DE, Perez CA, Brady LW, eds. Perez and Brady's principles and practice of Radiation Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2018. p. 6610-93.
  8. Reichl B, Block A, Schäfer U, Bert C, Müller R, Jung H, et al. DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk. Strahlenther Onkol 2015;191:701-9. [Crossref]  [PubMed]
  9. Scahue D, Marples B, Trott K.G. The effect of low dose X irradiation on the oxidative burst in stimulated macrophages. Int J Radiat Biol. 2002;78(7):567-76. [Crossref]  [PubMed]
  10. Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: Optimal ducha-Mak-ose. Hum Exp Toxicol. 2019;38(8):888-898. [Crossref]  [PubMed]
  11. Lattman I. Treatment of subacromial bursitis by roentgen irradiation. Am J Roentgen. 1936;36:55-60.
  12. Glatzel M, Baesecke S, Krauss A. Results of radiotherapy for refractory insertion tendinitis at trochanter major. [In German.] strahlenther Onkol. 2000; 176(suppl. 1):92.
  13. Olschewski T, Klein H. Functional radiotherapy for bursitis trochanterica. [In German.] Strahlenther Onkol. 2010;186(suppl.1):40.
  14. Biete A, Valduvieco I, Cases C, Fernández-Valencia J, Moreno LA, Del Amo M, et al Analgesic effects of low-dose radiotherapy in greater trochanteric pain syndrome: results in a clinical series of 155 patients with recurrent or refractory symptoms. Clin Transl Oncol. 2022;24(5):846-53. [Crossref]  [PubMed]
  15. Ott OJ, Hertel S, Gaipl US, Frey B, Schmidt M, Fietkau R. The Erlangen Dose Optimization Trial for radiotherapy of benign painful shoulder syndrome. Longterm results. Strahlenther Onkol. 2014;190(4):394-8. [Crossref]  [PubMed]
  16. Micke O, Ugrak E, Bartmann S, Adamietz IA, Schaefer U, Bueker R, et al. Radiotherapy for calcaneodynia, achillodynia, painful gonarthrosis, bursitis trochanterica, and painful shoulder syndrome - Early and late results of a prospective clinical quality assessment. Radiat Oncol. 2018;13(1):71. [Crossref]  [PubMed]  [PMC]
  17. Biete A, Valduvieco I, Arenas M, Holub K. Low-Dose Radiotherapy as an Effective Treatment of Trochanteric Bursitis in Elderly Patients. Ann Radiat Ther Oncol. 2017;1(1):1003.
  18. Micke O, Seegenschmiedt MH; German Working Group on Radiotherapy in Germany. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys. 2002;52(2):496-513. [Crossref]  [PubMed]
  19. Alvarez B, Montero A, Hernando O, Ciervide R, Garcia J, Lopez M, et al. Radiotherapy CT-based contouring atlas for non-malignant skeletal and soft tissue disorders: a practical proposal from spanish experience. Br J Radiol. 2021;94(1124):20200809. [Crossref]  [PubMed]  [PMC]
  20. Ott OJ, Hertel S, Gaipl US, Frey B, Schmidt M, Fietkau R. Benign painful elbow syndrome. First results of a single center prospective randomized radiotherapy dose optimization trial. Strahlenther Onkol. 2012;188(10):873-7. [Crossref]  [PubMed]
  21. Ng J, Shuryak I. Minimizing second cancer risk following radiotherapy: current perspectives. Cancer Manag Res. 2014;7:1-11. [Crossref]  [PubMed]  [PMC]
  22. Park SH, Lee JE. Radiotherapy, a New Treatment Option for Non-malignant Disorders: Radiobiological Mechanisms, Clinical Applications, and Radiation Risk. J Rheum Dis. 2017;24(2):74-84. [Crossref]